Title : Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia.

Pub. Date : 2002 Sep-Oct

PMID : 12410061






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Galantamine is an inhibitor of acetylcholinesterase and a positive allosteric modulator of nicotinic cholinergic receptors (with a FDA-approved indication for the treatment of patients with mild to moderate Alzheimer disease (AD) under the trade name Reminyl). Galantamine acetylcholinesterase (Cartwright blood group) Homo sapiens
2 Galantamine is distinguished from other acetylcholinesterase inhibitors by its positive allosteric modulatory properties, improving the efficiency of transduction of the acetylcholine signal at nicotinic receptors. Galantamine acetylcholinesterase (Cartwright blood group) Homo sapiens